Ask AI

Capsule Summaries

Share

Program Content

Activities

  • ACTG A5391 DO IT
    ACTG A5391/DO-IT Trial: Switching to DOR ± TDF vs Continuing INSTI + TAF/FTC in People With Obesity and HIV Infection
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 15, 2025

    Expires: January 14, 2026

  • Ulonivirine and Islatravir
    Switch to Ulonivirine + Islatravir in Adults With Virologically Suppressed HIV-1: Phase IIb Trial
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 15, 2025

    Expires: January 14, 2026

  • Real-world LA CAB + RPV With Viremia in OPERA
    Switch to LA CAB + RPV in People With HIV and Detectable Viral Load in OPERA Cohort
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 16, 2025

    Expires: January 15, 2026

  • TECAIN
    TECAIN: Randomized Trial of Topical Trichloroacetic Acid vs Electrocautery for AIN in People With HIV Infection
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 17, 2025

    Expires: January 16, 2026

  • SaDAPT
    SaDAPT: Same-Day ART for People With HIV and Presumptive TB in Lesotho and Malawi
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 17, 2025

    Expires: January 16, 2026

  • HBV Risk With LA ART
    IMPALA Subanalysis: Risk of de novo HBV Infection in Nonimmune People With HIV Using LA CAB + RPV ART
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 17, 2025

    Expires: January 16, 2026

  • VOLITION
    VOLITION: Interim Analysis From Phase IIIb Trial of Optional Switch to LA CAB + RPV Following ART Initiation on DTG/3TC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 17, 2025

    Expires: January 16, 2026

  • ODYSSEY Substudy
    ODYSSEY: Predictors of First-line ART Failure in Children With HIV
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 17, 2025

    Expires: January 16, 2026

  • Trio
    Predictors of Significant Weight Gain in People With HIV on ART in the Trio Cohort Over 3-Year Period: Retrospective Analysis
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 17, 2025

    Expires: January 16, 2026

  • BREATHER Plus
    BREATHER Plus: Short-Cycle vs Continuous ART in Adolescents Living With HIV Receiving DTG + TDF/3TC in Sub-Saharan Africa
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 17, 2025

    Expires: January 16, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner